After filing the 505(b)2 application for Rasuvo® (methotrexate injection) with the FDA, Medac Pharma needed to quickly build a commercial foundation for product …
Veeva Systems Inc (NYSE:VEEV) shares are down 21% today after the company released its fourth-quarter earnings, and announced its plans to acquire Qforma CrowdLink, a …
William Blair analyst Bhavan Suri reiterated an Outperform rating on Veeva Systems (NYSE:VEEV), following the company’s recent fiscal third-quarter results. The company reported results with …
In a research report issued today, William Blair analyst Bhavan Suri initiated coverage on Veeva Systems (NYSE:VEEV) with an Outperform rating. No price target was provided.
